Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-06-005812
Filing Date
2006-12-06
Accepted
2006-12-06 16:29:44
Documents
2
Period of Report
2006-12-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 7751
2 POA JR poajr.txt EX-24 1887
  Complete submission text file 0001005477-06-005812.txt   11506
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REPLIGEN CORP 41 SEYON ST. BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 7812500111
RUSCHE JAMES R (Reporting) CIK: 0001241031 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 061260390